Regulatory4 May 2026, 06:51 pm
Wockhardt QIP Proceeds Utilization Monitored by CRISIL
AI Summary
Wockhardt Ltd's monitoring agency report for the quarter ended March 31, 2026, confirms no deviation in the utilization of Qualified Institutions Placement (QIP) proceeds from the objects stated in the Placement Document dated November 11, 2024. CRISIL Ratings Limited issued the report, which was reviewed and taken on record by the Board of Directors & Audit Committee. The QIP issue period was from November 6, 2024, to November 11, 2024, with gross proceeds of ₹1,000.00 crores and net proceeds of ₹977.79 crores.
Key Highlights
- Wockhardt confirms no deviation in QIP proceeds utilization.
- CRISIL Ratings monitored the QIP proceeds for the quarter ended March 31, 2026.
- Net QIP proceeds were revised to ₹977.79 crores due to lower issue expenses.
- The Board of Directors & Audit Committee reviewed the monitoring report.
- QIP issue size: Gross proceeds of ₹1,000.00 crores.
Price Impact
More from WOCKPHARMA